earnings
ER
NASDAQ · ERNA
Ernexa Therapeutics Inc.
Healthcare · Biotechnology
$2.70
Down-$0.47 (-17.22%)
Updated Oct 6, 2026, 11:19 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 11.69M
- P/E ratio
- -0.67
- Dividend yield
- 0.00%
- 52-week range
- $0.18 – $15.88
- Volume
- 21.55K
- Avg. volume
- 3.57M
Price performance · ERNA
ERNA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
ERNA closed at $2.70 after 20 trading sessions, down 35.56% for the selected period.
- Last close
- $2.70
- Period change
- -35.56%
- Period low
- $2.70
- Period high
- $4.27
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $3.04 | $3.058 | $2.70 | $2.70 | 21.55K |
| Oct 2, 2026 | $3.00 | $3.2798 | $2.90 | $2.96 | 40.81K |
| Oct 1, 2026 | $3.13 | $3.2361 | $2.84 | $2.96 | 35.74K |
| Sep 30, 2026 | $3.24 | $3.47 | $3.16 | $3.20 | 42.64K |
| Sep 29, 2026 | $3.7382 | $3.7382 | $3.0444 | $3.16 | 61.87K |
| Sep 28, 2026 | $3.46 | $3.4999 | $3.20 | $3.47 | 25.79K |
| Sep 25, 2026 | $3.73 | $3.848 | $3.40 | $3.445 | 21.42K |
| Sep 24, 2026 | $3.785 | $3.8213 | $3.61 | $3.62 | 11.53K |
| Sep 23, 2026 | $3.73 | $3.79 | $3.65 | $3.65 | 6.24K |
| Sep 22, 2026 | $3.9599 | $3.9599 | $3.76 | $3.80 | 14.66K |
| Sep 21, 2026 | $4.01 | $4.01 | $3.75 | $3.96 | 13.5K |
| Sep 18, 2026 | $3.79 | $3.885 | $3.79 | $3.83 | 8.28K |
| Sep 17, 2026 | $4.04 | $4.08 | $3.7145 | $3.76 | 33.6K |
| Sep 16, 2026 | $4.01 | $4.155 | $3.84 | $3.91 | 22.56K |
| Sep 15, 2026 | $3.79 | $4.70 | $3.65 | $4.08 | 547.18K |
| Sep 14, 2026 | $4.13 | $4.40 | $4.13 | $4.27 | 16.83K |
| Sep 11, 2026 | $4.05 | $4.4199 | $4.03 | $4.165 | 19.82K |
| Sep 10, 2026 | $3.925 | $4.05 | $3.90 | $4.02 | 11.38K |
| Sep 9, 2026 | $4.20 | $4.23 | $3.97 | $4.02 | 15.65K |
| Sep 8, 2026 | $4.31 | $4.34 | $4.13 | $4.19 | 18.3K |
Latest ERNA news
The latest Smart Investors Daily articles mentioning ERNA.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

